REFERENCIAS

Referencias Introducción

Coffin J. Retroviridae: The viruses and their replication. In: Knipe DM HP, Griffin DE.
Fundamental Virology. Fourth ed. Philadelphia: Lippincott Williams & Wilkins; 2001. p. 1408.

Fleming PL, Wortley PM, Karon JM, DeCock KM, Janssen RS. Tracking the HIV epidemic:
current issues, future challenges. Am J Public Health 2000, 90(7):1037-1041.

Mahajan SD, Agosto-Mojica A, Aalinkeel R, ReynoldsJL, Nair BB, Sykes DE, Martinez J, Adams
J, Singh N, Hsiao CB, Schwartz SA. Role of chemokine and cytokine polymorphisms in the
progression of HIV-1 disease. Biochem Biophys Res Commun. 2010, 396(2): 348-352.

Mercenne G, Bernacchi S, Richer D, Bec G, Henriet S, Paillart JC, Marquet R. HIV-1 Vif binds
to APOBEC3G mRNA and inhibits its translation. Nucelic Acids Res. 2010, 38(2): 633-646.

Monjok E, Smesny A, Essien EJ. HIV/AIDS-related stigma and discrimination in Nigeria:

review of research studies and future directions for prevention strategies. Afr j Reprod
Health. 2009, 13(3): 21-35.

Ohmine S, Sakuma R, Sakuma T, Thatava T, Solis GP, Ikeda Y. Cytoplasmic body

component TRIM5{alpha} requires lipid-enriched microdomains for efficient HIV-1
restriction. J Biol Chem. 2010, 825(37) 3-27.

ONUSIDA. Resumen mundial de la epidemia VIH/SIDA. UNAIDS, Geneva, Switzerland,

2002.

Simon V, Ho DD, Abdool Karim Q. HIV/AIDS epidemiology, pathogenesis, prevention, and

treatment. Lancet 2006, 368(9534):489-504.

UNAIDS1. Male Circumcision: an intervention for HIV prevention in the WHO African
region. An informational note from the WHO regional office for Africa. UNAIDS, Geneva,
Switzerland, 2009.

UNAIDS2. Report on the global AIDS epidemic: The impact of AIDS on people and
societies. UNAIDS, Geneva, Switzerland, 2006.

UNAIDS/WHO. AIDS epidemic update Colombia; UNAIDS, Geneva, Switzerland, 2008.

Referencias Estado del arte

Chan DC, Kim PS. HIV entry and its inhibition. Cell 1998, 93(5): 681-684.

Wang WK, Chen MY, Chuang CY, Jeang KT, Huang LM. Molecular biology of
human immunodeficiency virus type 1. J Microbiol Immunol Infect 2000, 33(3): 131-40.

Coffin J. Retroviridae: The viruses and their replication. In: Knipe DM HP, Griffin DE, et al.,
editor. Fundamental Virology. Fourth ed. Philadelphia: Lippincott Williams & Wilkins; 2001. p.
1408.

Moore JP, McKeating JA, Weiss RA, Sattentau QJ. Dissociation of gp120 from HIV-1 virions
induced by soluble CD4. Science 1990, 250(4984): 1139-1142.

Fiorentini S, Giagulli C, Caccuri F, Magiera AK, Caruso A. HIV-1 matrix protein p17: A
candidate antigen for therapeutic vaccines against AIDS. Pharmacol Ther. 2010 [Epub
ahead of print]
Das AT, Berkhout B. HIV-1 evolution: frustrating therapies, but disclosing molecular
mechanisms. Philos Trans R Soc Lond B Biol Sci. 2010, 365(1548): 1965-1973.

Goff SP. Retroviral reverse transcriptase: synthesis, structure, and function. J Acquir
Immune Defic Syndr 1990, 3(8):817-831.

Vink C, Plasterk RH. The human immunodeficiency virus integrase protein. Trends Genet
1999, (12):433-438.

Arthur LO, Bess JW, Jr., Sowder RC, 2nd, Benveniste RE, Mann DL, Chermann JC, Henderson
LE. Cellular proteins bound to immunodeficiency viruses: implications for pathogenesis
and vaccines. Science 1992, 258(5090):1935-1938.

Briggs JA, Simon MN, Gross I Kräusslich HG, Fuller SD, Vogt VM, Johnson MC. The
stoichiometry of Gag protein in HIV-1. Nat Struct Mol, Biol. 2004, 11: 672-675.

Wei P, Garber ME, Fang SM, Fischer WH, Jones KA. A novel CDK9-associated C-type cyclin
interacts directly with HIV-1 Tat and mediates its high-affinity, loop-specific binding to
TAR RNA. Cell 1998, 92(4): 451-62.

de la Fuente C, Santiago F, Deng L, Eadie C, Zilberman I, Kehn K, et al. Gene expression

profile of HIV-1 Tat expressing cells: a close interplay between proliferative and
differentiation signals. BMC Biochem 2002 3: 14.

Yang OO, Nguyen PT, Kalams SA, Dorfman T, Gottlinger HG, Stewart S, et al. Nef-mediated
resistance of human immunodeficiency virus type 1 to antiviral cytotoxic T lymphocytes.
J Virol 2002, 76(4): 1626-1631.

Aiken C, Konner J, Landau NR, Lenburg ME, Trono D. Nef induces CD4 endocytosis:
requirement for a critical dileucine motif in the membrane-proximal CD4 cytoplasmic
domain. Cell 1994, 76(5): 853-864.

Collins KL, Chen BK, Kalams SA, Walker BD, Baltimore D. HIV-1 Nef protein protects
infected primary cells against killing by cytotoxic T lymphocytes. Nature 1998, 391(6665):
397-401.

Wang JK, Kiyokawa E, Verdin E, Trono D. The Nef protein of HIV-1 associates with rafts and
primes T cells for activation. Proc Natl Acad Sci U S A 2000, 97(1): 394-399.

Ferguson MR, Rojo DR, von Lindern JJ, O'Brien WA. HIV-1 replication cycle. Clin Lab Med
2002, 22(3): 611-635.

Arya SK, Guo C, Josephs SF, Wong-Staal F. Trans-activator gene of human Tlymphotropic
virus type III (HTLV-III). Science 1985, 229(4708): 69-73.

Turner BG, Summers MF. Structural biology of HIV. J Mol Biol 1999, 285(1): 1-32.

Luban J, Goff SP. Binding of human immunodeficiency virus type 1 (HIV 1) RNA to
recombinant HIV-1 gag polyprotein. J Virol 1991, 65(6): 3203-3212.

von Poblotzki A, Wagner R, Niedrig M, Wanner G, Wolf H, Modrow S. Identification of a

region in the Pr55gag-polyprotein essential for HIV-1 particle formation. Virology 1993,
193(2): 981-985.

Gottlinger HG, Sodroski JG, Haseltine WA. Role of capsid precursor processing and
myristoylation in morphogenesis and infectivity of human immunodeficiency virus type
1. Proc Natl Acad Sci USA 1989, 86(15):5781-5.

Bryant M, Ratner L. Myristoylation-dependent replication and assembly of human

immunodeficiency virus 1. Proc Natl Acad Sci USA 1990, 87(2):523-7.
Alvarez C, Salazar R, Galindez J, Rangel F, Castaãeda ML, Lopardo G, Cuhna CA, Roldan Y,
Sussman O, Gutierrez G, Cure-Bolt N, Seas C, Carcamo C, Castrillo M. Metabolic syndrome
in HIV-infected patients receiving antiretroviral therapy in Latin America. Braz J Infect Dis.
2010, 14(3): 256-263.

Pettit SC, Everitt LE, Choudhury S, et al. Initial cleavage of the human immunodeficiency
virus type 1 Gag/Pol precursor by its activated protease occurs by an intramolecular
mechanism. J Virol. 2004, 78: 8477-8485.

Bartel DP, Zapp ML, Green MR, et al. Rev regulation involves recognition of non-Watson-
Crick base pairs in viral RNA. Cell 1991, 67: 529-536.

Bischoff FR, Ponstingl H. Mitotic regulator protein RCC1 is complexed with a nuclear ras-
related polypeptide. Proc Natl Acad Sci USA, 1991, 88: 10830-10834.

Malim MH, McCRNA DF, Tiley LS, et al. Mutational definition of the human
immunodeficiency virus type 1 Rev activation domain. J Virol 1991, 65: 4248-4254.

Malim MH, Tiley LS, McCRNA DF, et al. HIV-1 Structural gene expression requires binding
of the Rev trans-activator to its RNA tAet sequence. Cell 1990, 60: 675-683.

Sadaie MR, Rappaport J, Benter T, et al. missense mutations in an infectious human

immunodeficiency viral genome: functional mapping of tat and identification of the rev
splice acceptor. Proc Natl Acad Sci USA, 1998, 85: 9224-9228.

Felber BK, Hadzopoulou-Cladaras M, Cladaras C, et al., Rev protein of human

immunodeficiency virus type 1 affects the stability and transport of the viral mRNA . Proc
Natl Acad Sci USA 1989, 86: 1495-1499.

Malim MH, Hauber J, Le SY et al., The HIV-1 rev transactivator acts through a structured
tAet sequence to activate nuclear export of unspliced viral mRNA. Nature 1989, 338: 254-
257.

Huang M, Orenstein JM, Martin MA, et al., p6Gag is required for particle production from full-
length human immunodeficiency virus type 1 molecular clones expressing protease. J
Virol 1995, 69: 6810-6818.

Urcuqui-Inchima S, Castaño ME, Hernandez-Verdun D, St-Laurent III G, Kumar A. Nuclear

Factor 90, a cellular dsRNA binding protein inhibits the HIV Rev-export function.
Retrovirology. 2006, 3:83.
Battiste JL, Mao H, Rao NS, et al. Alpha helix-RNA major groove recognition in an HIV-1
rev peptide-RRE RNA complex. Science 1996, 273: 1547-1551.

Zemmel RW, Kelley AC, KRNA J, et al. Flexible regions of RNA structure facilitates co-
operative Rev assembly on the Rev-response element. J Mol Biol 1996, 258: 763-777.

Mann DA, Mikaelian I, Zemmel RW, et al. A molecular rtheostat. Co-operative rev binding to
stem I of the rev-response element modulates human immunodeficiency virus type-1late
gene expression. J Mol Biol 1994, 241: 193-207.

Maldarelli F, Martin MA, Strebel K. Identification of posttranscriptionally active inhibitory

sequences in human immunodeficiency virus type 1RNA: novel level of gene regulation.
J Virol 1991, 65: 5732-5743.

Henderson BR, Percipalle P. interactions between HIV Rev and nuclear import and export
factors: the Rev nuclear localization signal mediates specific binding to human importin-
beta. J Mol Biol 1997, 274: 693-707.
Fornerod M, Ohno M, Yoshida M, et al CRM1 is an export receptor for leucine-rich nuclear
export signals. Cell 1997, 90: 1051-1060.

Askjaer P, Jensen TH, Nilsson J, et al. The specificity of CRM1-Rev nuclear export signal
interaction is mediated by RanGTP. J Biol Chem 1998, 273, 33414-33422.

Fukuda M, Asano S, Nakamura T, et al. CRM1 is responsible for intracellular transport

mediated by the nuclear export signal. Nature 1997, 390:308-311.

Nigg EA. Nucleocytoplasmic transport: signals, mechanisms and regulation. Nature 1997,
386: 779-787.

Hofmann W, Schubert D, LaBonte J, et al., Species-specific, postentry barriers to primate

immunodeficiency virus infection. J Virol 1999, 73: 10020-10028.

Cowan S, Hatziioannou T, Cunningham T, et al., Cellular inhibitors with Fv1-like activity

restrict human and simian immunodeficiency virus tropism. Proc Natl Acad Sci USA 2002,
99 11914-11919.

Song B, Gold B, O’Huigin C, et al The B30.2(SPRY) domain of the retroviral restriction

factor TRIM5alpha exhibits lineage-specific length and sequence variation in primates. J
Virol 2005, 79 6111-6121.

StremLau M, Perron M, Lee M, et al., Specific recognition and accelerated uncoating of

retroviral capsids by the TRIM5alpha restriction factor. Proc Natl Acad Sci USA 2006, 103:
5514-5519.

Patiño C, Urcuqui-Inchima S. Edición por APOBEC, un nuevo mecanismo de resistencia a

la infección por el VIH-1. Vitae 2008, 15:9-39.

Lecossier D, Bouchonnet F, Clavel F, HanceAJ. Hypermutation of HIV-1 DNA in the absence

of the Vif protein. Science. 2003, 300:1112.

Mehle A, Strack B, Ancuta P, Zhang C, McPike M, Gabuzda D. Vif overcomes the innate
antiviral activity of APOBEC3G by promoting its degradation in the ubiquitin-proteasome
pathway. J Biol Chem. 2004, 279:7792-7798.

References Factor nuclear 90

St Johnston D, Brown NH, Gall JG, Jantsch MA. 1992. A conserved double-stranded RNA-
binding domain. Proc. Natl, Acad: Sci. USA 89:10979-10983.

Fierro-monti I, Mathews MB. 2000. Protein binding to duplexed RNA: one motif, multiple
functions. Trends. Biochem. Sci. 25, 241-246.

Nicholson RH, Nicholson AW.  2002. Moleculra characterization of a mouse cDNA encoding
Dicer, a ribonuclease III ortholog involved in RNA interference. Mamm. Genome 13, 67-73.

Hurst SR, Hough RF, Aruscavage PJ, Bass BL. 1995. Deamination of mammalian glutamate
receptor RNA by Xenopus dsRNA adenosine deaminase: similarities to in vivo RNA
editing. RNA 1, 1051-1060.

Keegan LP, Gallo A, O’Connell MA. 2001. The many roles of an RNA editor. Nature Rev.
Genet. 2, 869-878.

Lui y, Lei M, Samuel CE. 2000. Chimeric doublé-strated RNA-specific adenosine

deaminase ADAR1 proteins reveal functional selectivity of double stranded RNA binding
domain from ADAR1 and protein kinase PKR. Proc. Natl. Acad. Sci. USA 97, 12541-12546.
Doyle M, Jantsch MF. 2003. New and old roles of the doublé-stranded RNA- binding
domain. J. Struc. Biol. 140, 147-153.

Eckmann CR, Neunteufl A, Pfaffstetter L, Jantsch MF. 2001. The human but not the Xenopus
RNA-editing enzyme ADAR1 has an typical nuclear localization signal and displays the
characteristics of a shuttling protein. Mol. Biol. Cell 12, 1911-1924.

Brownawell AM, Macara IG. 2002. Exportin-5, a novel karyopherin, mediates nuclear export
of double-stranded RNA binding proteins. J. Cell Biol. 156, 53-64.

Patel CV; Handy I, Goldsmith T, Patel RC. 2000. PACT, a stress-modulated cellular activator
of interferon-induced double stramded RNA-activated protein kinase, PKR. J. Biol. Chem.
275, 37993-37998.

Reichman TW, Parrot AM, Fierro-Monti I, Caron DJ, Kao PN, Lee CG, Li H, Mathews MB. 2003.
Selective regulation of gene expression by nuclear factor 110, a member of the NF90
family of double stranded RNA-binding proteins. J. Mol. Biol. 332, 85-98.

Larcher JC, Gasmi, L, Viranaichen W, Eddé B, Bernard R, Ginzburg I, Denoulet P. 2004. Ilf3
and NF90 associate with the axonal tAeting element of Tau mRNA. Faceb 14, 1761-1763.

Parrot AM, Walsh MR, Reichman TW, Mathews MB. 2005. RNA binding and phosphorylation
determine the intracellular distribution of nuclear factor 90 and 110. J. Mol. Biol. 348, 281-
923.

Corthésy B, Kao PN. 1994. Purification by DNA affinity crhomatography of two

polypeptides that contact the NF-AT DNA binding site in the interleukin 2 promotor. J.
Biol. Chem. 269, 20682-20690.

Kao PN, Chen L, Brock G, Ng J, Kenny J, Smith AJ, Corthésy B. 1994. Cloning and
expression of cyclosporine A- and FK506-sensitive nuclear factor of activated T-cells:
NF45 and NF90. J. Biol. Chem. 269, 20691-20699.

Matsumoto-Taniura N, Pirollet F, Monroe R, Gerace L, Westendorf JM. 1996. Identification of

novel M phase phosphoproteins by expression cloning. Mol. Biol. Cell. 7, 1455-1469.

Patel RC, Vestal DJ, Xu Z, Bandyopadhyay S, Guo W, Erme SM, Williams BR, Sen GC. 1999.
DRBP76, a double-stranded RNA-binding nuclear protein, is phosphorylated by the
interferon-induces protein kinase, PKR. J. Biol. Chem. 274, 20432-20437.

Saunders LR, Jurecic V, Barber GN. 2000. The 90- and 110- kDa Human NFAR proteins are
translated from two differentially spliced mRNA encoded on chromosome 19p13.
Genomics. 71, 256-259.

Duchange N, Pidoux J, Camus E, Sauvaget D. 2002. Alternative splicing in the human

interleukin enhancer binding factor 3 (ILF3) gene. Gene 261, 345-353.

Langland JO, Kao PN, Jacobs BL. 1999. Nuclear factor-90 of activated T-cell: a double-
stranded RNA-binding protein and substrate for the double –stranded RNA-dependent
protein kinase, PKR. Biochemistry. 38, 6361-6368.

Parrot AM, Walsh MR, Reichman TW, Mathews. 2005. RNA binding and phosphorylation
determine the intracellular distribution of nuclear factor 90 and 110. J. Mo. Biol. 348, 281-
293.

Pei Y, Zhu P, Dang Y, Wu J, Yang X, Wan B, Liu JO, Yi Q, Yu L. 2008. Nuclear export of
NF90 to stabilize IL-2 mRNA is mediated by AKT-dependent phosphorylation at ser647 in
response to CD28 costimulation. J. Immunol. 180, 222-229.
Referencias Materiales y Metodos

Krasnoselskaya-Riz I, Spruill A, Chen YW, Schuster D, Teslovich T, Baker C, Kumar A,

Stephan DA. Nuclear factor 90 mediates activation of the cellular antiviral expression
cascade. AIDS Res Hum Retroviruses. 2002, 18: 591-604.

Urcuqui-Inchima S, Castaño ME, Hernandez-Verdun D, St-Laurent III G, Kumar A. Nuclear

Factor 90, a cellular dsRNA binding protein inhibits the HIV Rev-export function.
Retrovirology. 2006, 3:83.

He J, and Landau NR. Use of a novel human immunodeficiency virus type 1 reporter virus
expressing human placental alkaline phosphatase to detect an alternative viral receptor.
J. Virol. 1995, 69(7): 4587-4592.

DuBridge RB, Tang P, Hsia HC, Leong PM, Miller JH, Carlos MP. Analysis of mutation in
human cells by using an Epstein-Barr virus shuttle system. Mol Cell Biol. 1987, 7(1): 379-
387.

Toohey K, Wehrly K, Nishio J, Perryman S, Chesebro B. Human immunodeficiency virus

envelope V1 and V2 regions influence replication efficiency in macrophages by affecting
virus spread. Virology. 1995, 213(1): 70-79.

Simon JH, Fouchier RA, Southerling TE, Guerra CB, Grant CK, Malim MH. The Vif and Gag
proteins of human immunodeficiency virus type 1 colocalize in infected human T cells. J
Virol. 1997, 71(7): 5259-5267.

Fouchier RA, Meyer BE, Simon JH, Fischer U, Malim MH. HIV-1 infection of non-dividing
cells: evidence that the amino-terminal basic region of the viral matrix protein is
important for Gag processing but not for post-entry nuclear import. EMBO J. 1997, 16(15):
4531-4539.

Simon JH, Carpenter EA, Fouchier RA, Malim MH. Vif and the p55(Gag) polyprotein of
human immunodeficiency virus type 1 are present in colocalizing membrane-free
cytoplasmic complexes. J Virol. 1999, 73(4): 2667-2674.

Taborda NA, Acevedo LY, Patino CP, Forero JE, López-Herrera A. Actividad antiviral in vitro
de extractos de Hura crepitans y Codiaeum variegatum en la replicación de Herpes Virus
Bovinos tipo-1 y Virus Estomatitis Vesicular. Rev Col Cienc Pec. 2007, 20: 241-249.

Tiedemann RE, Zhu YX, Schmidt J, Yin H, Shi CX, Que Q, Basu G, Azorsa D, Perkins LM,
Braggio E, Fonseca R, Bergsagel PL, Mousses S, Stewart AK. Kinome-wide RNAi studies in
human multiple myeloma identify vulnerable kinase tAets, including a lymphoid
restricted kinase, GRK6. Blood. 2010, 115: 1594-1604.

Referencias Resultados

Parrot AM, Walsh MR, Reichman TW, Mathews MB. RNA binding and phosphorylation
determine the intracellular distribution of nuclear factor 90 and 110. J. Mol. Biol. 2005,
348: 281-923.

Keegan LP, Gallo A, O’Connell MA. 2001. The many roles of an RNA editor. Nature Rev.
Genet. 2001, 2: 869-878.

Parker LM, Fierro-Monti I, Mathews MB. Nuclear factor 90 is a substrate and regulator of the
eukaryotic initiation factor 2 kinase double-stranded RNA-activated protein kinase. J Biol
Chem. 2001, 35: 32522-32530
Henderson BR, Percipalle P. interactions between HIV Rev and nuclear import and export
factors: the Rev nuclear localization signal mediates specific binding to human importin-
beta. J Mol Biol 1997, 274: 693-707.

Fornerod M, Ohno M, Yoshida M, et al CRM1 is an export receptor for leucine-rich nuclear

export signals. Cell 1997, 90: 1051-1060.

Doyle M, Jantsch MF.. New and old roles of the doublé-stranded RNA- binding domain. J.
Struc. Biol. 2003, 140: 147-153.

Wu S, Kaufman RJ. Trans-Autophosphorylation by the isolated kinase domain is not

sufficient for dimerization or activation of the dsRNA-activated protein kinase PKR.
Biochemistry. 2004, 34: 11027-11034.

Kao PN, Chen L, Brock G, Ng J, Kenny J, Smith AJ, Corthésy B. Cloning and expression of
cyclosporin A- and FK506-sensitive nuclear factor of activated T-cells: NF45 and NF90. J
Biol Chem. 1994, 32: 20691-20699.

Eckmann CR, Neunteufl A, Pfaffstetter L, Jantsch MF. The human but not the Xenopus RNA-
editing enzyme ADAR1 has an typical nuclear localization signal and displays the
characteristics of a shuttling protein. Mol. Biol. Cell. 2001, 12: 1911-1924.

Brownawell AM, Macara IG. 2002. Exportin-5, a novel karyopherin, mediates nuclear export
of double-stranded RNA binding proteins. J. Cell Biol. 2002, 156: 53-64.

Shi L, Godfrey WR, Lin J, Zhao G, Kao PN. NF90 regulates inducible IL-2 gene expression
in T cells. J Exp Med. 2007, 5: 971-977.

Pei Y, Zhu P, Dang Y, Wu J, Yang X, Wan B, Liu JO, Yi Q, Yu L. Nuclear export of NF90 to
stabilize IL-2 mRNA is mediated by AKT-dependent phosphorylation at Ser647 in
response to CD28 costimulation. J Immunol. 2008, 1: 222-229.

Zhu P, Jiang W, Cao L, Yu W, Pei Y, Yang X, Wan B, Liu JO, Yi Q, Yu L. IL-2 mRNA
stabilization upon PMA stimulation is dependent on NF90-Ser647 phosphorylation by
protein kinase. J Immunol. 2010, 9: 5140-5149.

Urcuqui-Inchima S, Castaño ME, Hernandez-Verdun D, St-Laurent III G, Kumar A. Nuclear

Factor 90, a cellular dsRNA binding protein inhibits the HIV Rev-export function.
Retrovirology. 2006, 3:83.

Briggs JA, Simon MN, Gross I Kräusslich HG, Fuller SD, Vogt VM, Johnson MC. The
stoichiometry of Gag protein in HIV-1. Nat Struct Mol, Biol. 2004, 11: 672-675.

Shin HJ, Kim SS, Cho YH, Lee SG, Rho HM. Host cell proteins binding to the encapsidation
signal epsilon in hepatitis B virus RNA. Arch Virol. 2002, 3: 471-491.

Isken O, Baroth M, Grassmann CW, Weinlich S, Ostareck DH, Ostareck-Lederer A, Behrens

SE. Nuclear factors are involved in hepatitis C virus RNA replication. RNA. 2007, 10:
1675-1692.

Wang P, Song W, Mok BW, Zhao P, Qin K, Lai A, Smith GJ, Zhang J, Lin T, Guan Y, Chen H.
Nuclear factor 90 negatively regulates influenza virus replication by interacting with viral
nucleoprotein. J Virol. 2009, 16: 7850-7861.

Agbottah ET, Traviss C, McArdle J, Karki S, St Laurent GC 3rd, Kumar A. Nuclear Factor
90(NF90) tAeted to TAR RNA inhibits transcriptional activation of HIV-1. Retrovirology.
2007, 12: 4:41.